FR - OX40: una diana terapéutica prometedora en la dermatitis atópica moderada-grave
Saved in:
| Main Authors: | M. Zulaika-Lloret, M. Rodriguez-Troncoso, R. Ruiz-Villaverde |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Actas Dermo-Sifiliográficas |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0001731024010548 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives
by: Alba Guglielmo, et al.
Published: (2025-05-01) -
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
by: James G. Krueger, et al.
Published: (2025-08-01) -
Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa
by: Thomas Leeuw, PhD, et al.
Published: (2025-08-01) -
OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia
by: Taizou Hirano, et al.
Published: (2016-03-01) -
Prognostic value of the co-stimulatory molecule OX40 expression in Extranodal Natural Killer/T-cell Lymphoma
by: Haiyan Zhang, et al.
Published: (2025-12-01)